Is TGTX a good stock to buy? We came across a bullish thesis on TG Therapeutics, Inc. on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on TGTX. TG Therapeutics, Inc.'s share was trading at $50.54 as of June 16th. TGTX’s trailing and forward P/E were 17.59 and 38.76 respectively according to Yahoo Finance.
[caption id="attachment_564437" align="aligncenter" width="750"]TG Therapeutics, Inc. (TGTX) is a commercial-stage biopharmaceutical company focused on treating multiple sclerosis, positioned within...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.